Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults
Open accessAbstract
Excessive utilization of laboratory diagnostic testing leads to increased health care costs. We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral pathogens in cerebrospinal fluid (CSF) samples from adults. This is a single-center split retrospective observational study with a screening cohort from 2008 to 2012 and a validation cohort from 2013. Adults with available results for herpes simplex virus 1/2 (HSV-1/2), varicella-zoster virus (VZV), cytomegalovirus (CMV), or enterovirus (EV) NAAT with CSF samples between 2008 and 2013 were included (n = 10,917). During this study, 1.3% (n = 140) of viral NAAT studies yielded positive results. The acceptance criteria of >10 nucleated cells/μl in the CSF of immunocompetent subjects would have reduced HSV-1/2, VZV, CMV, and EV testing by 63%, 50%, 44%, and 51%, respectively, from 2008 to 2012. When these criteria were applied to the 2013 validation data set, 54% of HSV-1/2, 57% of VZV, 35% of CMV, and 56% of EV tests would have been cancelled. No clinically significant positive tests would have been cancelled in 2013 with this approach. The introduction of a computerized order entry set was associated with increased test requests, suggesting that computerized order sets may contribute to unnecessary testing. Acceptance criteria of >10 nucleated cells/μl in the CSF of immunocompetent adults for viral CSF NAAT assays would increase clinical specificity and preserve sensitivity, resulting in significant cost savings. Implementation of these acceptance criteria led to a 46% reduction in testing during a limited follow-up period.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous studies showed a safe reduction in herpes virus testing using a cutoff of 10×10^6 CSF leukocytes per liter in non-immunocompromised patients.
“In these studies, the authors showed a safe reduction in herpes virus testing using a cutoff of 10 × 106 CSF leukocytes pro liter in non-immunocompromised patients (23, 25).”
From Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel – a retrospective study to develop a diagnostic decision rule (2024) · cites this paper as [23]
Cites
Cassel, C. K. (2012) · JAMA · doi:10.1001/jama.2012.476 · Cited by 939 · see citing works
Enterovirus Surveillance - United States, 1970-2005: (540562006-001)
Khetsuriani, N., LaMonte-Fowlkes, A., Oberste, M. S., & Pallansch, M. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e540562006-001 · Cited by 702 · see citing works
Lakeman, F. D., & Whitley, R. J. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.857 · Cited by 662 · see citing works
Etiology of aseptic meningitis and encephalitis in an adult population
Kupila, L., Vuorinen, T., Vainionpää, R., Hukkanen, V., Marttila, R. J., & Kotilainen, P. (2006) · Neurology · doi:10.1212/01.wnl.0000191407.81333.00 · Cited by 388 · see citing works
Ramers, C. (2000) · JAMA · doi:10.1001/jama.283.20.2680 · Cited by 291 · see citing works
Choosing wisely in pediatric hospital medicine: Five opportunities for improved healthcare value
Quinonez, R. A., Garber, M. D., Schroeder, A. R., Alverson, B. K., Nickel, W. K., Goldstein, J. D., Bennett, J. S., Fine, B. R., Hartzog, T. H., McLean, H. S., et al. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2064 · Cited by 249 · see citing works
Viral infections of the central nervous system in Spain: A prospective study
de Ory, F., Avellón, A., Echevarría, J. E., Sánchez‐Seco, M. P., Trallero, G., Cabrerizo, M., Casas, I., Pozo, F., Fedele, G., Vicente, D., et al. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23470 · Cited by 180 · see citing works
Update on Herpes Virus Infections of the Nervous System
Steiner, I., & Benninger, F. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0414-8 · Cited by 180 · see citing works
Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results
Jeffery, K. J., Read, S. J., Peto, T., Mayon-White, R. T., & Bangham, C. R. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08107-x · Cited by 163 · see citing works
Choosing wisely in adult hospital medicine: Five opportunities for improved healthcare value
Bulger, J. B., Nickel, W. K., Messler, J., Goldstein, J. D., O'Callaghan, J. P., Aurón, M., & Gulati, M. S. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2063 · Cited by 155 · see citing works
Brackbill, R. M., Thorpe, L. E., DiGrande, L., Perrin, M. A., Sapp, J. H., Wu, D., Campolucci, S. S., Walker, D. J., Cone, J., Pulliam, P., et al. (2006) · PsycEXTRA Dataset · doi:10.1037/e506912006-001 · Cited by 154 · see citing works
ROBINSON, C. C., WILLIS, M., MEAGHER, A., GIESEKER, K. E., ROTBART, H., & GLODÉ, M. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00005 · Cited by 131 · see citing works
CNS Manifestations of Cytomegalovirus Infections
Maschke, M., Kastrup, O., & Diener, H. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00003 · Cited by 122 · see citing works
Tiège, X. D., Héron, B., Lebon, P., Ponsot, G., & Rozenberg, F. (2003) · Clinical Infectious Diseases · doi:10.1086/374839 · Cited by 100 · see citing works
Nigrovic, L. E., & Chiang, V. W. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.8.817 · Cited by 98 · see citing works
Multiplex, Quantitative, Real-Time PCR Assay for Cytomegalovirus and Human DNA
Sanchez, J. L., & Storch, G. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2381-2386.2002 · Cited by 96 · see citing works
Studahl, M., Lindquist, L., Eriksson, B.-M., Günther, G., Bengner, M., Franzen-Röhl, E., Fohlman, J., Bergström, T., & Aurelius, E. (2013) · Drugs · doi:10.1007/s40265-013-0007-5 · Cited by 90 · see citing works
Effective Use of Polymerase Chain Reaction for Diagnosis of Central Nervous System Infections
Tang, Y., Hibbs, J. R., Tau, K. R., Qingfang, Q., Skarhus, H. A., Smith, T. F. A., & Persing, D. H. (1999) · Clinical Infectious Diseases · doi:10.1086/520439 · Cited by 82 · see citing works
Volpp, K. G. M., Loewenstein, G. F., & Asch, D. A. (2012) · JAMA · doi:10.1001/jama.2012.13616 · Cited by 68 · see citing works
Simko, J. P., Caliendo, A. M., Hogle, K., & Versalovic, J. (2002) · Clinical Infectious Diseases · doi:10.1086/341979 · Cited by 64 · see citing works
Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid
Hanson, K. E., Alexander, B. D., Woods, C., Petti, C., & Reller, L. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01950-06 · Cited by 56 · see citing works
Clifford, D. B., Buller, R. S., Mohammed, S., Robison, L., & Storch, G. A. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.75 · Cited by 53 · see citing works
Choosing Wisely: Highest‐cost tests in outpatient neurology
Burke, J. F., Skolarus, L. E., Callaghan, B. C., & Kerber, K. A. (2013) · Annals of Neurology · doi:10.1002/ana.23865 · Cited by 41 · see citing works
Interpretation of positive molecular tests of common viruses in the cerebrospinal fluid
Bhaskaran, A., Racsa, L. D., Gander, R. M., Southern, P., Cavuoti, D., & Alatoom, A. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.07.017 · Cited by 33 · see citing works
López-Roa, P., Alonso, R., de Egea, V., Usubillaga, R., Muñóz, P., & Bouza, E. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00950-13 · Cited by 33 · see citing works
Bettigole, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1307295 · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Messacar, K., Parker, S. K., Todd, J. K., & Dominguez, S. R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02264-16 · Cited by 329 · see citing works
Hanson, K. E., & Couturier, M. R. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw494 · Cited by 99 · see citing works
Graf, E. H., Farquharson, M. V., & Cárdenas, A. M. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.022 · Cited by 71 · see citing works
Varicella zoster virus infections in neurological patients: a clinical study
Skripuletz, T., Pars, K., Schulte, A. J., Schwenkenbecher, P., Yildiz, Ö., Ganzenmueller, T., Kuhn, M., Spreer, A., Wurster, U., Pul, R., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3137-2 · Cited by 71 · see citing works
Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01255-16 · Cited by 52 · see citing works
Messacar, K., Palmer, C., Gregoire, L., Elliott, A., Ackley, E., Perraillon, M. C., Tyler, K. L., & Dominguez, S. R. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.02.002 · Cited by 34 · see citing works
Appropriate Use and Future Directions of Molecular Diagnostic Testing
Graf, E. H., & Pancholi, P. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-0714-5 · Cited by 29 · see citing works
Messacar, K., Gaensbauer, J. T., Birkholz, M., Palmer, C., Todd, J. K., Tyler, K. L., & Dominguez, S. R. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115085 · Cited by 20 · see citing works
Erba, A., Franzeck, F. C., Hinic, V., Egli, A., & Osthoff, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1351903 · Cited by 15 · see citing works
Hauser, R. G., Campbell, S. M., Brandt, C., & Wang, S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00119-17 · Cited by 15 · see citing works
Valencia‐Shelton, F., Anderson, N., Palavecino, E. L., Navas, M. E., Larkin, P. M. K., She, R. C., & Filkins, L. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.00941-24 · Cited by 14 · see citing works
McCreery, R., Nielsen, L., Clarey, D., Murphy, C., & Van Schooneveld, T. C. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115605 · Cited by 11 · see citing works
Ngo Nsoga, M. T., Pérez-Rodriguez, F. J., Mamin, A., L’Huillier, A. G., Cherkaoui, A., Kaiser, L., & Schibler, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03179-22 · Cited by 11 · see citing works
Expanding Molecular Diagnostics for Central Nervous System Infections
Gutierrez, M., & Emmanuel, P. J. (2018) · Advances in Pediatrics · doi:10.1016/j.yapd.2018.04.005 · Cited by 11 · see citing works
Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis
Morrison, A. R., Jones, M. C., Makowski, C. T., Samuel, L. P., Ramadan, A. R., Alangaden, G. J., Davis, S. L., & Kenney, R. M. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115571 · Cited by 9 · see citing works
Starolis, M. W., Zaydman, M. A., & Liesman, R. M. (2023) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.10.009 · Cited by 6 · see citing works
Messacar, K., Robinson, C. C., & Dominguez, S. R. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0174 · Cited by 6 · see citing works
Sample Selection, Preservation, Transport, and Storage
Dunn, J. J., & Graf, E. H. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch11 · Cited by 4 · see citing works
Interpretation and Relevance of Advanced Technique Results
Stratton, C. W., & Tang, Y. (2018) · Springer eBooks · doi:10.1007/978-3-319-95111-9_31 · Cited by 3 · see citing works
An Electronic Health Record Intervention to Limit Viral Testing of Cerebrospinal Fluid
Lyman, K. A., Madill, E. S., Thatikunta, P., Threlkeld, Z. D., Banaei, N., & Gold, C. A. (2023) · The Neurohospitalist · doi:10.1177/19418744231152103 · Cited by 3 · see citing works
Clinical Decision Support Tools for Microbiology Laboratory Testing
Jackups, R. (2020) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2020.02.001 · Cited by 2 · see citing works
Self-citationMcGuire, J. L., Tuite, N. V., Swami, S. K., & Avery, R. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7307 · Cited by 1 · see citing works
Enteroviruses and Parechoviruses
Stellrecht, K. A., Lamson, D. M., & Romero, J. R. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0091
Enteroviruses and Parechoviruses
Stellrecht, K. A., Lamson, D. M., & Romero, J. R. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0091
Maucione, C., Farnsworth, C. W., & Zaydman, M. A. (2026) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfag024
CSF Testing for Neuroinvasive West Nile Virus and Measures to Improve Guideline Adherence
Quinn, C. M., Singh, K., Singh, A., Turbett, S. E., Kanjilal, S., Harrold, G. K., Solomon, I. H., Venna, N., Pastula, D. M., Chauhan, L., et al. (2026) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200634
- Authors
- Wilen, C. B., Monaco, C. L., Hoppe-Bauer, J., Jackups, R., Bucelli, R. C., & Burnham, C.-A. D.
- Affiliations
- Washington University in St. Louis (US)
- Department of Laboratories, Barnes-Jewish Hospital, St. Louis, Missouri, USA
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2015-03
- Volume
- 53
- Issue
- 3
- Pages
- 887-895
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC4390640
- OpenAlex
- W1963762085
- Cited by
- 27
- References
- 27
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 1
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (T32AI007172)
- Topics
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Keywords
- unnecessary laboratory testing, cerebrospinal fluid, herpes simplex virus, varicella-zoster virus, cytomegalovirus, enterovirus, nucleic acid amplification tests, CSF cell count, immunocompetent adult, computerized physician order entry, health care costs
- MeSH terms
- Adult, Aged, Cerebrospinal Fluid, Costs and Cost Analysis, Cytomegalovirus, Enterovirus, Humans, Leukocyte Count, Leukocytes, Mononuclear, Meningitis, Aseptic, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Herpesvirus 3, Human, Cohort Studies, Simplexvirus, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review